HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Total Other Income Expenses Net

Last Annual Value

124.00K

3-Year CAGR

22%

5-Year CAGR

20%

10-Year CAGR

7%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of Total Other Income Expenses Net

BEAT · NASDAQ
CompanyTotal Other Income Expenses Net
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
124.00K
-43.2%N/AN/A 
1.24M
-11.2%N/AN/A
-2.45M
N/AN/AN/A
419.00K
-33.4%55.6%145.8%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
-4.85M
N/AN/AN/A
286.00K
-44.4%N/AN/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
1.29M
-1.0%72.7%52.0%
-12.40M
N/AN/AN/A
-6.96K
N/AN/AN/A
-145.00K
N/AN/AN/A
-2.07M
N/AN/AN/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47